ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.
ThinkCyte has raised $14.8M in total funding. The most recent round was Series C. The last funding was announced in August 2024.
ThinkCyte's investors include SBI Investment, SMBC Venture Capital, UntroD Capital, Global Brain Corporation, SkyDeck Berkeley.
ThinkCyte is headquartered in Hongo, Japan.
ThinkCyte is a biotechnology company that provides sorting of cells for various applications in research, diagnostics, and therapeutics.
ThinkCyte is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ThinkCyte — Funding & Investors." VCBacked, August 29, 2024, https://www.vcbacked.co/company/thinkcyte. Accessed October 11, 2026.
VCBacked. (2024). ThinkCyte — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/thinkcyte
{{cite web |title=ThinkCyte — Funding & Investors |url=https://www.vcbacked.co/company/thinkcyte |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated